Innovative Medical Management Co Ltd (002173) - Net Assets
Based on the latest financial reports, Innovative Medical Management Co Ltd (002173) has net assets worth CN¥1.66 Billion CNY (≈ $243.27 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥2.05 Billion ≈ $299.91 Million USD) and total liabilities (CN¥387.09 Million ≈ $56.64 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how strategically is Innovative Medical Management Co Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥1.66 Billion |
| % of Total Assets | 81.11% |
| Annual Growth Rate | 15.73% |
| 5-Year Change | -11.38% |
| 10-Year Change | -50.04% |
| Growth Volatility | 162.91 |
Innovative Medical Management Co Ltd - Net Assets Trend (2004–2025)
This chart illustrates how Innovative Medical Management Co Ltd's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see Innovative Medical Management Co Ltd stock valuation.
Annual Net Assets for Innovative Medical Management Co Ltd (2004–2025)
The table below shows the annual net assets of Innovative Medical Management Co Ltd from 2004 to 2025. Also explore Innovative Medical Management Co Ltd equity growth rate to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥1.76 Billion ≈ $258.19 Million |
-0.71% |
| 2024-12-31 | CN¥1.78 Billion ≈ $260.05 Million |
-5.02% |
| 2023-12-31 | CN¥1.87 Billion ≈ $273.80 Million |
-1.79% |
| 2022-12-31 | CN¥1.91 Billion ≈ $278.80 Million |
-4.30% |
| 2021-12-31 | CN¥1.99 Billion ≈ $291.33 Million |
-7.16% |
| 2020-12-31 | CN¥2.14 Billion ≈ $313.80 Million |
-13.18% |
| 2019-12-31 | CN¥2.47 Billion ≈ $361.43 Million |
-31.70% |
| 2018-12-31 | CN¥3.62 Billion ≈ $529.21 Million |
-1.08% |
| 2017-12-31 | CN¥3.66 Billion ≈ $534.98 Million |
+3.51% |
| 2016-12-31 | CN¥3.53 Billion ≈ $516.83 Million |
+754.42% |
| 2015-12-31 | CN¥413.37 Million ≈ $60.49 Million |
-13.63% |
| 2014-12-31 | CN¥478.62 Million ≈ $70.04 Million |
-4.57% |
| 2013-12-31 | CN¥501.53 Million ≈ $73.39 Million |
-3.59% |
| 2012-12-31 | CN¥520.22 Million ≈ $76.12 Million |
+11.63% |
| 2011-12-31 | CN¥466.02 Million ≈ $68.19 Million |
+7.29% |
| 2010-12-31 | CN¥434.36 Million ≈ $63.56 Million |
+7.54% |
| 2009-12-31 | CN¥403.89 Million ≈ $59.10 Million |
+3.14% |
| 2008-12-31 | CN¥391.58 Million ≈ $57.30 Million |
+11.92% |
| 2007-12-31 | CN¥349.87 Million ≈ $51.20 Million |
+160.76% |
| 2006-12-31 | CN¥134.18 Million ≈ $19.63 Million |
+31.11% |
| 2005-12-31 | CN¥102.34 Million ≈ $14.98 Million |
+24.65% |
| 2004-12-31 | CN¥82.10 Million ≈ $12.01 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Innovative Medical Management Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 11337.6% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | CN¥3.18 Billion | 181.89% |
| Total Equity | CN¥1.75 Billion | 100.00% |
Innovative Medical Management Co Ltd Competitors by Market Cap
The table below lists competitors of Innovative Medical Management Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Mahanagar Gas Limited
NSE:MGL
|
$1.16 Billion |
|
The India Cements Limited
NSE:INDIACEM
|
$1.16 Billion |
|
Harbin Xinguang Optic Electronics
SHG:688011
|
$1.16 Billion |
|
ScanSource Inc
NASDAQ:SCSC
|
$1.16 Billion |
|
Hotai Finance Corp
TW:6592
|
$1.15 Billion |
|
Chengdu Haoneng Tech Co Ltd
SHG:603809
|
$1.15 Billion |
|
Hengbao Co Ltd
SHE:002104
|
$1.15 Billion |
|
Heritage Financial Corporation
NASDAQ:HFWA
|
$1.15 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Innovative Medical Management Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,776,198,085 to 1,749,891,597, a change of -26,306,488 (-1.5%).
- Net loss of 34,854,476 reduced equity.
- Dividend payments of 2,590,902 reduced retained earnings.
- Other comprehensive income decreased equity by 43,827,802.
- Other factors increased equity by 54,966,693.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥-34.85 Million | -1.99% |
| Dividends Paid | CN¥2.59 Million | -0.15% |
| Other Comprehensive Income | CN¥-43.83 Million | -2.5% |
| Other Changes | CN¥54.97 Million | +3.14% |
| Total Change | CN¥- | -1.48% |
Book Value vs Market Value Analysis
This analysis compares Innovative Medical Management Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.51x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 38.51x to 4.51x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2004-12-31 | CN¥0.46 | CN¥17.89 | x |
| 2005-12-31 | CN¥0.57 | CN¥17.89 | x |
| 2006-12-31 | CN¥0.73 | CN¥17.89 | x |
| 2007-12-31 | CN¥1.95 | CN¥17.89 | x |
| 2008-12-31 | CN¥1.76 | CN¥17.89 | x |
| 2009-12-31 | CN¥1.87 | CN¥17.89 | x |
| 2010-12-31 | CN¥1.92 | CN¥17.89 | x |
| 2011-12-31 | CN¥2.12 | CN¥17.89 | x |
| 2012-12-31 | CN¥2.38 | CN¥17.89 | x |
| 2013-12-31 | CN¥2.54 | CN¥17.89 | x |
| 2014-12-31 | CN¥2.21 | CN¥17.89 | x |
| 2015-12-31 | CN¥2.02 | CN¥17.89 | x |
| 2016-12-31 | CN¥8.00 | CN¥17.89 | x |
| 2017-12-31 | CN¥8.05 | CN¥17.89 | x |
| 2018-12-31 | CN¥8.53 | CN¥17.89 | x |
| 2019-12-31 | CN¥5.43 | CN¥17.89 | x |
| 2020-12-31 | CN¥4.71 | CN¥17.89 | x |
| 2021-12-31 | CN¥4.44 | CN¥17.89 | x |
| 2022-12-31 | CN¥4.28 | CN¥17.89 | x |
| 2023-12-31 | CN¥4.21 | CN¥17.89 | x |
| 2024-12-31 | CN¥4.03 | CN¥17.89 | x |
| 2025-12-31 | CN¥3.97 | CN¥17.89 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Innovative Medical Management Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -1.99%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -4.46%
- • Asset Turnover: 0.36x
- • Equity Multiplier: 1.25x
- Recent ROE (-1.99%) is below the historical average (1.30%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2004 | 24.40% | 11.35% | 1.05x | 2.05x | CN¥10.14 Million |
| 2005 | 18.09% | 8.02% | 0.76x | 2.97x | CN¥6.90 Million |
| 2006 | 23.73% | 10.99% | 0.64x | 3.40x | CN¥15.17 Million |
| 2007 | 11.10% | 12.13% | 0.49x | 1.88x | CN¥3.51 Million |
| 2008 | 10.51% | 10.86% | 0.52x | 1.85x | CN¥1.83 Million |
| 2009 | 3.21% | 4.15% | 0.37x | 2.11x | CN¥-24.89 Million |
| 2010 | 7.28% | 9.94% | 0.35x | 2.10x | CN¥-10.73 Million |
| 2011 | 7.08% | 9.09% | 0.37x | 2.13x | CN¥-12.41 Million |
| 2012 | 7.98% | 10.34% | 0.36x | 2.12x | CN¥-9.64 Million |
| 2013 | 4.73% | 7.93% | 0.28x | 2.10x | CN¥-26.44 Million |
| 2014 | -2.27% | -5.91% | 0.18x | 2.17x | CN¥-58.70 Million |
| 2015 | -15.81% | -47.68% | 0.13x | 2.60x | CN¥-106.67 Million |
| 2016 | 3.25% | 15.04% | 0.17x | 1.29x | CN¥-238.44 Million |
| 2017 | 3.85% | 16.74% | 0.18x | 1.27x | CN¥-224.81 Million |
| 2018 | 0.82% | 2.95% | 0.24x | 1.18x | CN¥-331.91 Million |
| 2019 | -46.58% | -131.85% | 0.29x | 1.20x | CN¥-1.40 Billion |
| 2020 | -14.67% | -43.42% | 0.27x | 1.25x | CN¥-528.85 Million |
| 2021 | -5.20% | -14.54% | 0.28x | 1.28x | CN¥-302.45 Million |
| 2022 | -3.86% | -10.35% | 0.30x | 1.23x | CN¥-263.86 Million |
| 2023 | -1.83% | -4.26% | 0.35x | 1.22x | CN¥-221.30 Million |
| 2024 | -5.29% | -11.51% | 0.37x | 1.24x | CN¥-271.57 Million |
| 2025 | -1.99% | -4.46% | 0.36x | 1.25x | CN¥-209.84 Million |
Industry Comparison
This section compares Innovative Medical Management Co Ltd's net assets metrics with peer companies in the Luxury Goods industry.
Industry Context
- Industry: Luxury Goods
- Average net assets among peers: $1,865,801,987
- Average return on equity (ROE) among peers: 8.08%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Innovative Medical Management Co Ltd (002173) | CN¥1.66 Billion | 24.40% | 0.23x | $1.16 Billion |
| Shenzhen Tellus Holding Co Ltd (000025) | $277.22 Million | 2.05% | 2.10x | $846.62 Million |
| Fiyta Holdings Ltd (000026) | $679.49 Million | 9.50% | 1.12x | $1.06 Billion |
| Guangdong CHJ Industry Co Ltd (002345) | $2.72 Billion | 7.25% | 0.68x | $1.16 Billion |
| Zhejiang Ming Jewelry Co Ltd (002574) | $3.14 Billion | 2.78% | 0.24x | $388.63 Million |
| Beijing Kingee Culture Development Co Ltd (002721) | $908.61 Million | 7.58% | 2.36x | $1.06 Billion |
| Shenyang Cuihua Gold and Silver Jewelry Co Ltd (002731) | $1.62 Billion | 10.65% | 2.23x | $28.86 Million |
| Chow Tai Seng Jewellery Co Ltd (002867) | $3.97 Billion | 20.31% | 0.48x | $1.64 Billion |
| Shenzhen Tellus Holding Co Ltd (200025) | $1.10 Billion | 7.91% | 0.51x | $19.50 Million |
| Fiyta Holdings Ltd (200026) | $2.37 Billion | 4.66% | 0.69x | $45.07 Million |
About Innovative Medical Management Co Ltd
Innovative Medical Management Co.,Ltd. engages in the medical services business in China. The company owns and operates Jianhua Hospital, Kanghua Hospital, Futian Hospital, and Mingzhu Hospital. It also offers outpatient, inpatient, rehabilitation services, and medical examination services. In addition, it offers supply chain management and procurement of pharmaceuticals, medical consumables, and… Read more